GSK plc (GSK)
$46.92+0.90%Close
SELLRECOVERY · day 20
Key stats
Short interest · FINRA settlement 2026-09-30
52-week IV4.7%–67.7%
- Market cap
- $94.7B
- Beta
- 0.29
- Div yield
- 3.90%
- P/E (TTM)
- 14.71
- IV-%ile
- 6
- IV ATM
- 17.8%
- Short % float
- 0.76%
- Days to cover
- 4.1
- SI change
- +1.0%
- 1W
- +0.79%
- 1M
- -2.51%
- vs SPY 1W
- +0.37%
- vs SPY 1M
- -4.57%
Industry peers
FMP comparable companies · ranked by market cap
- LLYBUYEli Lilly and Company$1.1TRECOVERYQ 21$1179.27+0.28%
- JNJSELLJohnson & Johnson$630.0BBEARQ 22$261.44+0.88%
- MRKSELLMerck & Co., Inc.$359.6BBEARQ 11$145.60-0.10%
- RHHBYRoche Holding AG$344.8B$54.09
- NVSBUYNovartis AG$273.2BRECOVERYQ 20$143.75+0.06%
- AZNSELLAstraZeneca PLC$246.9BRECOVERYQ 20$159.20-0.55%
- AMGNBUYAmgen Inc.$223.9BRECOVERYQ 22$414.87+0.65%
- NVOSELLNovo Nordisk A/S$171.6BRECOVERYQ 20$38.64-0.16%
- PFESELLPfizer Inc.$161.2BBULLQ 13$28.28+0.42%
- SNYSELLSanofi$96.2BBEARQ 11$40.07-0.82%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on GSK?
- LOPJLB’s latest quantitative signal on GSK plc (GSK) is SELL in a RECOVERY regime. Signals are updated daily.
- What market regime is GSK in?
- GSK plc (GSK) is currently classified in the RECOVERY HMM market regime on LOPJLB.
- What does GSK plc (GSK) do?
- GSK plc, a global pharmaceutical entity founded in 1715 and headquartered in Brentford, United Kingdom, dedicates its efforts to the research, development, and manufacturing of a wide array of medical solutions. Until May 2022, the company was known as GlaxoSmithKline plc. Its primary objective is to prevent and treat illnesses by producing both vaccines and a comprehensive range of specialty a…